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ABSTRACT
Although stress can suppress growth and prolifer-
ation, cells can induce adaptive responses that
allow them to maintain these functions under
stress. While numerous studies have focused on
the inhibitory effects of stress on cell growth, less
is known on how growth-promoting pathways influ-
ence stress responses. We have approached this
question by analyzing the effect of mammalian
target of rapamycin (mTOR), a central growth con-
troller, on the osmotic stress response. Our results
showed that mammalian cells exposed to moderate
hypertonicity maintained active mTOR, which was
required to sustain their cell size and proliferative
capacity. Moreover, mTOR regulated the induction
of diverse osmostress response genes, including
targets of the tonicity-responsive transcription
factor NFAT5 as well as NFAT5-independent
genes. Genes sensitive to mTOR-included regula-
tors of stress responses, growth and proliferation.
Among them, we identified REDD1 and REDD2,
which had been previously characterized as mTOR
inhibitors in other stress contexts. We observed that
mTOR facilitated transcription-permissive condi-
tions for several osmoresponsive genes by
enhancing histone H4 acetylation and the recruit-
ment of RNA polymerase II. Altogether, these
results reveal a previously unappreciated role of
mTOR in regulating transcriptional mechanisms
that control gene expression during cellular stress
responses.
INTRODUCTION
The mammalian target of rapamycin (mTOR) Ser/Thr
kinase belongs to the family of PI3-kinase-related
kinases (PIKK) and is a central regulator of cell growth
and proliferation due to its ability to activate the biosyn-
thesis of proteins, nucleic acids and lipids in response to
growth-promoting signals (1). The pool of mTOR mol-
ecules is distributed into two main protein complexes
with distinct functions, mTORC1 and mTORC2, which
are deﬁned by speciﬁc accessory proteins, such as raptor
in mTORC1 (2,3), and rictor and Sin1 in mTORC2 (4,5).
mTORC1 is activated by growth factors, nutrients and
energy. The mTORC1 complex has substantial inﬂuence
in growth and proliferation due to its ability to regulate
the translation of diverse proteins involved in ribosome
biogenesis and cell cycle control (1), by activating the
ribosomal S6 subunit kinases (S6K) 1 and 2 (6), and
inactivating the translation repressor 4E-BP1 (7).
mTORC1 also inﬂuences, by direct and indirect mechan-
isms, the expression of genes involved in the control of
metabolism, ribosomal biogenesis, growth and prolifer-
ation (8–12). mTORC2 was ﬁrst described as a regulator
of the actin cytoskeleton (4,13), but also regulates cell
growth, differentiation and proliferation (14), at least in
part by enhancing the activity of mTORC1 via activation
and stabilization of Akt (15,16). mTORC1 and mTORC2
differ in their sensitivity to rapamycin, a bacterial product
that binds to the intracellular chaperone FKBP12 to form
a complex capable of binding with high afﬁnity and spe-
ciﬁcity to the FRB domain of mTOR. This domain is ac-
cessible to the rapamycin-FKBP12 complex when mTOR
is alone or forming part of mTORC1. Rapamycin rapidly
suppresses the activity of mTORC1 towards many,
although not all, of its substrates (17,18), but does not
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formation of new mTORC2 complexes, which in the long
term can lead to the inhibition of mTORC2-dependent
functions (19).
Besides its responsiveness to growth regulatory condi-
tions, mTOR is also sensitive to diverse stressors, such as
hypoxia, DNA damage, oxidative stress and osmotic
stress (20). DNA damage induces the p53-dependent ex-
pression of Sestrins 1 and 2 (21), and hypoxia induces the
HIF-1a-mediated expression of REDD1 and REDD2
(22), all of which can activate TSC2 (20,21). TSC2 has
GTPase activity and inhibits mTORC1 by converting its
activator Rheb-GTP to Rheb-GDP (23). Energy stress in
general causes the increase in the intracellular [AMP]/
[ATP] ratio and engages the AMP-activated kinase
AMPK, which phosphorylates and activates TSC2 (24).
AMPK can also inhibit mTORC1 directly by
phosphorylating raptor (25). The decrease in mTOR
activity in cells exposed to stress serves to slow down or
arrest growth and proliferation-promoting processes when
cells face conditions that can damage critical components
such as DNA. The importance of inhibiting mTOR during
stress is illustrated by the ﬁnding that TSC2
/ cells
cannot shut down mTOR when exposed to glucose depriv-
ation or DNA damage and exhibit mTOR-dependent ac-
cumulation of p53 and cell death (26,27). The capacity of
mTOR to inﬂuence stress responses is also evidenced by its
ability to increase the translation and activity of the
hypoxia-inducible factors HIF-1a and HIF-2a (28,29).
These observations raise the question of whether growth
signaling pathways are merely less active under stress or
may also regulate the quality and magnitude of stress re-
sponses. We have addressed this question by analyzing the
effect of mTOR in the response of mammalian cells to
hypertonic stress.
The effects of hypertonic stress on mammalian cells
depend on its intensity and duration. In mammals,
normal tonicity in most tissues is 300mOsm/kg, corres-
ponding to a concentration of extracellular sodium plus
potassium ions of 150mM. An exception is the renal
medulla, where local tonicity can reach 600–1700mOsm/
kg. However, this elevated tonicity is not entirely caused
by sodium ions, but is in part contributed by a high con-
centration of urea, which actually helps renal medullary
cells to tolerate hypertonicity (30). Hypertonicity levels
of 400mOsm/kg and higher can also occur in other
sites, such as the skin and respiratory and gastrointes-
tinal mucosa, as result of hypernatremia caused by
dietary and ambient conditions (31–33). In addition,
systemic hypernatremia with plasma tonicities of
360–430mOsm/kg, which would affect multiple tissues,
can result from severe dehydration and osmoregulatory
disorders (34–40). Studies have shown that elevated hyper-
tonicity (>600mOsm/kg) can cause double-strand DNA
breaks (41) and induce a genotoxic stress response (30),
with activation of ATM and the checkpoint effectors p53
and Chk2 (42,43). However, cells exposed to moderate
osmostress conditions of 400–500mOsm/kg, which are
more likely to reﬂect physiopathological settings, exhibit
only a transient genotoxic stress-like response and revers-
ible cell cycle arrest without evident DNA damage (44),
and can maintain their proliferative capacity under pro-
longed hypertonic conditions (40,44–48). Mammalian
cells react to osmostress by activating the transcription
factor NFAT5/TonEBP, which contains a Rel-like
DNA-binding domain homologous to those of NF-kB
and the calcineurin-dependent NFATc proteins (49–51).
NFAT5 controls the expression of numerous osmo-
protective gene products, including chaperones of the
Hsp family (52,53), enzymes involved in osmolyte synthe-
sis, and osmolyte transporters (49,54–56), and regulates
the adaptation to hypertonicity in cell types as diverse as
renal medullary cells (46), embryonic ﬁbroblasts (46,47),
neurons (39) or lymphocytes (40,44,47). NFAT5 deﬁ-
ciency in the mouse causes a severe renal dysfunction
(46) and T-cell immunodeﬁciency associated with the in-
ability of NFAT5-deﬁcient cells to adapt to hypertonic
stress conditions in vivo (40,47).
With regard to mTOR and osmostress, it had been
described that elevated hypertonicity (600–900mOsm/kg)
inactivated the mTOR pathway (57–59), although some
had reported a transient stimulation of S6K1 activity by
hypertonic shock (60). A possible mechanism for mTOR
inhibition during osmostress might involve AMPK, since
this kinase can be activated by elevated hypertonicity
(61,62). However, intense hypertonic stress might not ac-
curately reﬂect conditions in which cells would mount an
adaptive response, since acute elevation of tonicity
>600mOsm/kg can induce cell death in hours (45), and
impair the osmoprotective function of NFAT5 (47). On
the other hand, we and others had observed that the
activity of NFAT5 in response to more moderate
osmostress (500mOsm/kg) was enhanced in cells with
active PI3-kinase (63) or stimulated with mitogens (64),
which suggests that growth-promoting signals might
have a positive effect on survival responses to osmostress.
In this regard, earlier work had shown that at least in
some organisms, such as yeast, TOR promoted cell
survival to salt stress (65,66).
In view of these observations, we asked whether mTOR
was active in mammalian cells exposed to moderate
osmostress conditions, and if so, whether it contributed
to the induction of an adaptive gene expression
program. We report that hypertonicity conditions of
500mOsm/kg do not inactivate mTORC1 nor mTORC2
in mouse embryo ﬁbroblasts (MEFs). Moreover, mTOR
activity was required for cell growth and proliferation
under osmostress. By using pharmacological mTOR in-
hibitors and mRNA microarray analysis of MEFs,
we found that mTOR regulated the expression of
osmostress-sensitive genes, which comprised regulators
of stress responses, cell survival and proliferation, and
included NFAT5-dependent and -independent targets, re-
vealing an inﬂuence of mTOR on genes with different
transcriptional requirements. Among them, we identiﬁed
REDD1, previously characterized as an mTOR inhibitor
in other stress contexts. Suppression of REDD1 affected
the expression of various genes induced by osmotic stress,
suggesting a regulatory role in the osmostress response.
Our results also showed that mTOR enhanced the acetyl-
ation of histone H4 at the promoters and transcribed
regions of osmostress-induced genes, and the recruitment
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the transcription of stress response genes by inﬂuencing
their chromatin conﬁguration and RNA polymerase
function. These results reveal a previously unappreciated
role of mTOR in regulating transcriptional mechanisms
that control gene expression during cellular stress
responses.
MATERIALS AND METHODS
Cells
The human embryonic kidney cell line HEK293 was
obtained from the American Type Culture Collection
(ATCC). HEK293T cells were kindly provided by Josep
Lluı´s Parra (Vall d’Hebron Institute of Oncology).
AMPKa1/a2 double knockout MEFs were kindly
provided by Benoit Viollet (INSERM, Institut Cochin,
CNRS and Universite ´ Paris Descartes) and Tomi
Makela (Institute of Biotechnology, University of
Helsinki). Brieﬂy, MEFs were obtained from 12.5-day
mouse embryos from Prkaa1(AMPKa1)
/, Prkaa2
(AMPKa2)-ﬂoxed mice (AMPKa1
/, AMPKa2
ﬂ/ﬂ)o f
mixed background (Bl6/CD1) (67). Deletion of
AMPKa2 was done by infecting the cells in vitro with
Adeno-Cre, and cells were immortalized at passage 2
with a carboxy-terminal fragmentof p53 (68,69). Wild-
type-AMPK MEFs were immortalized by the same pro-
cedure. Wild-type and NFAT5-deﬁcient MEFs were
prepared from 13.5-day littermate embryos (129sv back-
ground) using the NIH3T3 protocol to obtain spontan-
eously immortalized cells (46). HEK293 cells and MEFs
were maintained in Dulbecco’s modiﬁed Eagle’s Medium
(DMEM) (Gibco) supplemented with 10% heat-
inactivated fetal bovine serum, 4mM L-glutamine
(Gibco), 1mM sodium pyruvate (Gibco) and 50mM
b-mercaptoethanol (Gibco). Splenocytes from 8- to
12-weeks-old wild-type and Nfat5
/ mice (46) were
isolated by density gradient sedimentation with
Lymphoprep (Axis-Shield PoC AS) and stimulated with
2.5mg/ml concanavalin A (Sigma-Aldrich) plus 25ng/ml
of IL-2 (Chiron) during 24h in culture medium containing
DMEM supplemented with 10% heat-inactivated fetal
bovine serum, 2mM L-glutamine, 1mM sodium
pyruvate, 50mM b-mercaptoethanol, penicillin–strepto-
mycin and non-essential amino acids (Gibco) and then
cultured under isotonic or hypertonic conditions as
indicated in the ﬁgure legend.
Hypertonic stress
The osmolarity of the culture medium was measured in a
VAPRO 5520 vapor pressure osmometer (Wescor).
Culture medium with supplements had an osmolality of
330mOsm/kg, and was adjusted to 300mOsm/kg by
adding 10% sterile H2O (Milli-Q Biocel A10, Millipore).
Media were made hypertonic by adding NaCl from a
sterile 4M stock solution in water. Over an isotonic
baseline of 300mOsm/kg, addition of 50mM NaCl
raised the osmolarity to 400mOsm/kg and 100mM
NaCl to 500mOsm/kg. In some experiments, sorbitol
(200mM ﬁnal concentration) was used to induce
osmotic stress.
Real-time quantitative PCR (RT–qPCR)
Total RNA was isolated using the High Pure RNA isola-
tion kit (Cat. 11828665001, Roche) following manufac-
turer’s instructions. 1–2mg of total RNA were
retrotranscribed to cDNA using SuperScript III reverse
transcriptase and random primers (Invitrogen). For
real-time quantitative PCR, LightCycler 480 SYBR
Green I Master Mix (Cat. 11608521, Roche) and a
LightCycler480 system apparatus (Roche) were used fol-
lowing the instructions provided by the manufacturers.
Samples were normalized to L32 mRNA levels using the
LightCycler 480 SW 1.5 software (Roche).
Microarray experiments and analysis
NIH3T3-immortalized wild-type and NFAT5-deﬁcient
MEFs (46) from passages 30–35 were plated (175000
cells in 60-mm dishes) in isotonic medium and 2 days
later were either left untreated or treated for 8h with
500mOsm/kg. When indicated, the mTOR catalytic in-
hibitor Torin1 was added 1h before hypertonicity
(500mOsm/kg) treatment. Cells were lysed in RLT
buffer (300ml, RNeasy system, QIAGEN Cat. 74104)
and total RNA was isolated using the manufacturer
protocol. The RNA integrity was assessed using Agilent
2100 Bioanalyzer (Agilent), and only samples with high
integrity [RNA integrity number (RIN)>7.5] were subse-
quently used in microarray experiments. Ampliﬁcation,
labeling and hybridizations were performed according to
protocols from Ambion and Affymetrix. Brieﬂy, 250ng of
total RNA were ampliﬁed using the Ambion WT
Expression Kit (Ambion/Applied Biosystems), labeled
using the WT Terminal Labeling Kit (Affymetrix Inc),
and then hybridized to Mouse Gene 1.0 ST Array
(Affymetrix) in a GeneChip Hybridization Oven 640.
Washing and scanning were performed using the
Hybridization Wash and Stain Kit and the GeneChip
System of Affymetrix (GeneChip Fluidics Station 450
and GeneChip Scanner 3000 7G). Three independent
microarray hybridizations were performed for each ex-
perimental condition: cells maintained at 300mOsm/kg
or exposed to 500mOsm/kg (8h) without or with
100nM Torin1 in the case of wild-type MEFs, or
300mOsm/kg and 500mOsm/kg for Nfat5
/ MEFs.
Microarray data analysis was performed as follows: after
quality control of raw data, it was background-corrected,
quantile-normalized and summarized to a gene level using
the robust multi-chip average (RMA) (70) obtaining a
total of 28853 transcript clusters, excluding controls,
which roughly correspond to genes. Core annotations
(version NetAffx 30, human genome 18) were used to
summarize data into transcript clusters. Linear Models
for Microarray (LIMMA) (71), a moderated t-statistics
model, was used for detecting differentially expressed
genes between the conditions in study. Correction for
multiple comparisons was performed using false discovery
rate. Genes with an adjusted P-value < 0.05 or with a
P<0.01 for those comparisons with few results after
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Hierarchical cluster analysis was also performed to
analyze how data aggregated and linear model for regres-
sion purposes. All data analysis was performed in R
(version 2.11.1) with packages aroma.affymetrix,
Biobase, Affymetrix, LIMMA and geneﬁlter. The micro-
array data have been deposited in NCBI’s Gene
Expression Omnibus and are accessible through GEO
Series accession number GSE27485.
Cell viability, cell-size determination and
proliferation assays
Flow cytometry was done with a BD LSR ﬂow cytometer
(BD Biosciences). For viability and cell-cycle analysis,
cells were labeled with 5mg/ml of the DNA dye Hoechst
33342 (SIGMA) in suspension in cytometry tubes for 1h
at 37C in a water bath. Viability was determined by
forward and side scatter parameters (FSC/SSC) in the
total population of cells. Non-viable cells were readily
identiﬁed by their distinct position in the FSC/SSC
plots. Cell size (FSC parameter) was analyzed in the popu-
lation of cells in G1 phase, after staining with the DNA
dye Hoechst 33342. Cell proliferation was analyzed
in CFDA-SE-labeling experiments. Brieﬂy, MEFs were
labeled with 5mM carboxyﬂuorescein diacetate
succinimidyl ester (CFDA-SE, Molecular Probes,
Invitrogen) at Day 0 and then analyzed at 48 and 72h
after labeling. The decrease in CFDA-SE ﬂuorescence in-
tensity in cells, which was proportional to the number of
cell divisions, was analyzed by two-color ﬂow cytometry in
the population of live cells, identiﬁed by staining with
Hoechst 33342 and excluding cells with a sub-G0/G1
DNA content.
RNA interference assays
ON-TARGETplus SMARTpool small interfering RNA
(siRNA) pools were purchased from Dharmacon:
nontargeting scramble (D-001810-10), mouse Ddit4/
REDD1 (L-056656-01) and mouse Ddit4l/REDD2
(L-056952-00). siRNA (40nM) was transfected using
Lipofectamine 2000 (Invitrogen) in a six-well plate
format following the manufacturer’s protocol.
Chromatin immunoprecipitation
Two days before stimulation 0.410
6 MEFs (wild-type-
AMPK) were plated in 10-cm diameter dishes and 1 day
before applying the stimulus the medium was replaced by
fresh isotonic one. Cells were treated during the indicated
times with 500mOsm/kg with or without Torin1 (100nM)
pretreatment. Cells were ﬁxed with 1% formaldehyde for
10min at room temperature and with continuous agita-
tion. Formaldehyde was then quenched with glycine (ﬁnal
concentration of 125mM) for 5min. After washing the
plates twice with cold PBS and once with cold PBS +
PMSF, cells were lysed in SDS lysis buffer [50mM Tris–
HCl pH 8.1, 1% SDS, 10mM EDTA and protease in-
hibitor cocktail set III, EDTA-free (Cat. 539134,
Calbiochem)] for 5–10min and then stored at 80C for
at least 24h. Lysates were sonicated in 1.5ml polypropyl-
ene tubes with a bath sonicator (Diagenode Bioruptor) for
eight cycles of 30 s on and 30 s off on high power for cells
stimulated for 4h and six cycles for cells stimulated 8h,
to obtain DNA fragments between 500 and 1000bp, and
centrifuged 10min at 18000g to remove insoluble
debris. Supernatants were collected and 10% of each
sample was separated to use as a measure of chromatin
input for normalization. The rest of the sample was
diluted 10 times in ChIP dilution buffer (16.7mM Tris–
HCl pH 8.1, 0.01% SDS, 1.1% Triton X-100, 1.2mM
EDTA, 167mM NaCl and protease inhibitor cocktail
set III, EDTA free) for immunoprecipitation. Samples
were precleared with protein A-sepharose beads
(Amersham, cat. 17-0780-01) that had been pre-adsorbed
with 57mg/ml salmon sperm DNA (Roche, cat.
11467140001) and 0.1mg/ml of bovine serum albumin
(BSA) (New England Biolabs) by rocking for 1h at 4C.
After removing the preclearing beads, the speciﬁc
antibodies were added to the lysates and incubated over-
night at 4C in rotation. Protein A-Sepharose beads
pre-adsorbed with 60mg/ml salmon sperm DNA and
0.1mg/ml of BSA were then added, incubated for 3–4h at
4C, and then washed once with low salt wash buffer
(20mM Tris–HCl pH 8.1, 0.1% SDS, 1% Triton X-100,
2mM EDTA, 150mM NaCl), once with high salt wash
buffer (20mM Tris–HCl pH 8.1, 0.1% SDS, 1% Triton
X-100, 2mM EDTA, 500mM NaCl), once with LiCl
immune complex wash buffer (10mM Tris–HCl pH 8.1,
250mM LiCl, 1% NP40, 1% sodium deoxycholate, 1mM
EDTA) and twice with 1 TE (10mM Tris–HCl pH 8.1
and 1mM EDTA). To elute the DNA, beads were
incubated with 200ml elution buffer (1% SDS and
100mM NaHCO3) for 20min at room temperature with
shaking. To reverse the crosslinking, samples were
incubated overnight at 65C with 1mg RNase per sample
(Roche, cat. 11119915001) and 200mM NaCl ﬁnal
concentration. DNA was puriﬁed using the QIAGEN
PCR puriﬁcation system (Cat. 28104). DNA was then
subjected to real time quantitative PCR (RT–qPCR)
with the primers described in Supplementary Methods.
Immunoprecipitated DNA from each sample was
normalized to its respective chromatin input.
Statistical analysis
The statistical signiﬁcance of the experimental data was
determined with paired Student’s t-test.
Reagents, antibodies and primers, western blots, luciferase
reporter assays and ﬂuorescence microscopy
The detailed list of reagents (AICAR, rapamycin, Torin1
and general chemicals), antibodies (western blot, chroma-
tin immunoprecipitation and immunoﬂuorescence) and
primers used for mRNA analysis and chromatin
immunoprecipitation is provided in Supplementary
‘Materials and Methods’ section. Likewise, the description
of western blotting, luciferase reporter assays and ﬂuores-
cence microscopy experiments are also included in
Supplementary ‘Materials and Methods’ section.
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mTOR remains active under sustained osmotic stress and
regulates the induction of osmostress response genes
As a ﬁrst approximation to analyze whether mTOR could
inﬂuence the osmotic stress response in mammalian cells,
we ﬁrst tested whether this pathway was active during
hypertonic stress conditions of 500mOsm/kg, that were
strong enough to induce a robust osmoadaptive gene ex-
pression response but not so high that they would
suppress cell growth and proliferative capacity. Analysis
of diagnostic substrates downstream mTORC1
(phosphorylated-S235/236 in the ribosomal subunit S6,
and phosphorylation-dependent electrophoretic mobility
shift of 4E-BP1) and mTORC2 (phosphorylated S473 of
Akt) showed that although osmostress caused a partial
inhibition of both mTOR complexes in MEFs, they
retained substantial activity under hypertonic stress
(Figure 1A and Supplementary Figure S1A). The induc-
tion of NFAT5 observed in the same experiment served as
an indicator of the ongoing osmostress response. This ex-
periment also showed that rapamycin speciﬁcally inhibited
mTORC1, but not mTORC2, in MEFs exposed to
osmotic stress, whereas both mTOR complexes were efﬁ-
ciently inhibited by Torin1, an ATP-competitive mTOR
inhibitor whose mechanism of action is unrelated to that
of rapamycin (18) (Figure 1A). We then tested the effect of
rapamycin and Torin1 on the expression of the endogen-
ous mRNAs of several osmoresponsive genes in response
to hypertonic stress (500mOsm/kg) induced by either
hypernatremia or sorbitol (Figure 1A). Comparison of
both inhibitors on the induction of Akr1b3 (aldose reduc-
tase), Aqp1 (aquaporin 1), Hspa1b (Hsp70.1) and Slc5a3
(sodium/myoinositol cotransporter, SMIT) showed that
Torin1 was moderately stronger than rapamycin
(Figure 1B). Relative mRNA levels for the osmostress-
induced genes were obtained after normalization to L32
mRNA, which we had previously compared with another
usual normalization control, Gapdh, and conﬁrmed as in-
sensitive to mTOR inhibitors (Supplementary Figure
S1B). Experiments also showed that rapamycin and
Torin1 caused a stronger inhibition of gene expression at
later time points (Figure 1C), in parallel with the progres-
sive inactivation of mTOR (Figure 1A). Analysis of inde-
pendent cell types yielded similar results, as we observed
that induction of Hspa1b, Slc5a3 and Slc6a6 (sodium and
chloride-dependent taurine transporter, TauT) by osmotic
stress (400mOsm/kg) in mitogen-activated splenocytes
was also sensitive to rapamycin (Supplementary Figure
S2A), and that rapamycin caused a signiﬁcant inhibition
of the osmostress-induced, NFAT5-activated ORE-Luc
reporter activity in the human embryonic kidney cell line
HEK293 and MEFs (Supplementary Figure S2B). The
ﬁnding that mTORC2 was active in rapamycin-treated
MEFs exposed to osmostress indicated that the
downregulation of gene expression caused by rapamycin
was due to the inhibition of mTORC1, and suggested that
the greater potency of Torin1 likely reﬂected its ability to
inhibit mTORC1-dependent functions better than
rapamycin (18). This interpretation was also supported
by the observation that Torin1 caused a complete
dephosphorylation of the mTORC1 substrate 4E-BP1
(Figure 1A), whereas rapamycin had a partial effect, in
agreement with previous publications (17,18).
Since it had been reported that AMPK can be transi-
ently activated by intense osmotic stress conditions
(>600mOsm/kg) (61,62), we tested whether the lower
osmostress levels used in our assays activated AMPK.
Our results showed that hypertonic conditions of
500mOsm/kg had minimal or no effect on the
LKB1-mediated phosphorylation of AMPKa in T172, in
contrast with the strong phosphorylation induced by the
AMPK activator AICAR (Supplementary Figure S3A).
Experiments using AMPKa1/a2-double knockout MEFs
(Supplementary Figure S3B) showed that wild-type and
AMPKa-null cells exhibited similar inducibility and
rapamycin sensitivity of osmostress response genes
(Supplementary Figure S3C), indicating that AMPK
does not have a strong effect on mTOR activity and ex-
pression of osmoregulatory genes under moderate
osmostress conditions.
Identiﬁcation of mTOR-regulated genes in the osmotic
stress response
The results above showed that mTOR was active in
proliferating cells exposed to physiopathologic osmostress
conditions and contributed to enhance the expression of
several osmoprotective genes. In order to get a broader
picture of genes whose expression was regulated by
osmostress and sensitive to mTOR, we used RNA micro-
array analysis in MEFs. RNA from three independently
performed experiments was analyzed with the Affymetrix
Mouse Gene 1.0 ST array. The experiments included
a parallel analysis of osmoresponsive genes in
NFAT5-deﬁcient MEFs to identify NFAT5-dependent
genes. Cells were exposed to hypertonic stress for 8h,
since our previous experiments (Figure 1C) had shown
that this time point was sufﬁcient for robust induction
of osmotic stress response genes, but not so long that
cells had fully adjusted to a hypertonic environment (48)
nor to the prolonged inhibition of mTOR (12). For these
assays, we used Torin1 instead of rapamycin because it
had a stronger effect in downregulating osmostress
response genes and we considered that it would allow a
clearer identiﬁcation of mTOR-regulated genes when
comparing independent samples in the microarray
analysis. The results revealed that Torin1 signiﬁcantly
affected the expression of numerous genes in cells
exposed to osmotic stress (Figure 2A). We identiﬁed 107
genes that were induced by osmotic stress 2 times with a
P<0.01, of which 24 (22%) were repressed by Torin1 by
at least 35% (Supplementary Table S1). This analysis also
showed that another 74 genes were repressed by 50% by
osmotic stress, and the inhibition of eight of them (11%)
was attenuated by Torin1 (Supplementary Table S2). We
detected few mRNAs that were consistently inhibited by
Torin1 at 8h, and none upregulated, in non-stressed cells
(Supplementary Table S3). This modest effect likely re-
ﬂected that inhibition of mTOR for the last 9h in cells
that until then had been growing actively had a limited
impact on the representation of preexisting mRNAs.
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downregulated the expression of 12 genes, and increased
the expression of 2, that were not signiﬁcantly affected by
either osmotic stress or Torin1 alone (Supplementary
Table S4). These results indicated that mTOR regulated
the induction and repression of a selective pattern of
osmostress responsive genes. Comparison of wild-type
and NFAT5-deﬁcient MEFs showed that 74% (79 of
107) of the genes induced by osmostress were regulated
by NFAT5, of which 17 (22%) were Torin1-sensitive
(Supplementary Table S1). Of 28 NFAT5-independent
genes, Torin1 inhibited the induction of 7 (25%)
of them. Therefore, although a majority of the genes
strongly induced by osmostress were NFAT5-regulated,
there was no association between the dependence on
NFAT5 and sensitivity to mTOR inhibition.
We validated by RT–qPCR a sample of 14 genes chosen
by their robust induction by osmostress in the microarray
experiments, and also illustrative of Torin1-sensitive and
-insensitive, as well as NFAT5-dependent and -independ-
ent genes (Figure 2B). This analysis conﬁrmed the
sensitivity to Torin1 of the NFAT5-dependent genes
Ddit4, Ddit4l, Slc1a3 and the NFAT5-independent
Amd1, Bpgm and Slc19a2 (Figure 2B). Also consistent
Figure 1. Effect of rapamycin and Torin1 on the induction of osmostress response genes. (A) MEFs immortalized with a p53-carboxy-terminal
fragment (immortalized MEFs) were cultured in isotonic (300mOsm/kg) or hypertonic medium (500mOsm/kg, upon addition of 100mM NaCl)
without or with rapamycin (50nM) or Torin1 (100nM). NFAT5, phospho-S6 (Ser 235/236), S6, phospho-AKT (Ser 473), AKT, 4E-BP1 and b-actin
(loading control) were detected by Western blotting. One representative experiment is shown (other experiments are shown in Supplementary
Figure S1). (B) RNA was isolated from immortalized MEFs cultured in isotonic (300mOsm/kg) medium or medium made hypertonic
(500mOsm/kg) by addition of 100mM NaCl or 200mM sorbitol, during 8h without or with 50nM rapamycin (Ra) or 100nM Torin1 (T1).
mRNA abundance for Akr1b3, Aqp1, Hspa1b and Slc5a3 normalized to L32 mRNA is represented relative to hypertonic conditions (100%).
Bars represent the mean±SEM of ﬁve independent experiments (*P<0.05). (C) RNA was isolated from immortalized MEFs cultured in
isotonic (300mOsm/kg) or hypertonic medium (500mOsm/kg, upon addition of 100mM NaCl) without or with rapamycin (50nM) or Torin1
(100nM). mRNA abundance for Akr1b3 and Slc5a3 normalized to L32 mRNA is represented relative to the 8-h time point (100%). Bars represent
the mean±SEM of four independent experiments (*P<0.05).
Nucleic Acids Research, 2012,Vol.40, No. 10 4373Figure 2. Identiﬁcation of osmostress-regulated genes and their sensitivity to mTOR inhibition. (A) Scatter plot in which the gray dots represent the
expression pattern of the entire dataset and the blue crosses the genes whose induction by osmostress was repressed by Torin1 or whose repression by
osmostress was attenuated by Torin1. The panels in the right show the heat maps of the gene probes found to be regulated by osmostress and their
sensitivity to Torin1. Expression levels correspond to the log2 of the mean of three independent samples per condition (center panel) and for each
individual sample (right panel). The brightness of red (induced) and green (downregulated) represents the magnitude of the change in the expression
of each gene. Gene names and values are provided in Supplementary Tables S1–S4. (B) RT–qPCR validation of Torin1 sensitivity of osmoresponsive
genes identiﬁed in the microarray analysis. RNA from the three individual samples used for the microarray analysis plus one additional experiment
were analyzed by RT–qPCR for the expression of the indicated genes and normalized to L32. Samples correspond to wild-type MEFs cultured in
isotonic (I, white bars) (300mOsm/kg) or hypertonic (H, black bars) medium (500mOsm/kg) during 8h without or with Torin1 (100nM). RNA
levels are represented relative to the amount of mRNA in hypertonic conditions, which was given an arbitrary value of 100. Bars represent the
mean±SEM of four independent experiments (*P<0.05).
4374 Nucleic Acids Research, 2012,Vol.40, No. 10with the microarray data, Torin1 had minimal or no effect
on the induction of the NFAT5-dependent Hist1h1d and
Kcnj2, and the NFAT5-independent genes Fosl1, Itga3,
Prl2c3/c5 and Slc39a10 (Figure 2B). We observed that
Akr1b3, Aqp1 and Mrps6 had not scored as
Torin1-sensitive with sufﬁcient statistical signiﬁcance in
the microarray, but showed to be inhibited by Torin1
when analyzed by RT–qPCR. This result likely reﬂects
differences in sensitivity between both techniques, and
suggests that the number of osmoresponsive genes that
could be affected by mTOR inhibition might be greater
than detected in the microarray experiments. Analysis of
several genes representative of different degrees of sensi-
tivity to Torin1, Amd1, Bpgm, Ddit4, Ddit4l and Mrps6,i n
an independent MEF line conﬁrmed that they were also
inhibited by rapamycin (Supplementary Figure S4), simi-
larly to what we had previously observed with Akr1b3,
Aqp1, Hspa1b and Slc5a3 (Figures 1B and 2B).
Besides genes with already known osmoprotective func-
tions, such as Akr1b3, Aqp1, Hspa1b and Slc5a3
(38,49,72,73), mTOR regulated the expression of others
that had not been previously shown to respond to
osmostress, although they had been described in the
context of other stress responses: Ddit4 and Ddit4l in
hypoxia, DNA damage and oxidative stress (74), Figf/
VEGF-D (75) in hypoxia, and Slc19a2 in DNA damage
(76) (Supplementary Tables S1–S5). Some of the
Torin1-inhibited genes encoded for positive regulators of
proliferation: Amd1 (77), Figf/VEGF-D (78) and Tacstd2/
Trop2 (79) (Supplementary Table S1). The set of genes
repressed by osmostress and whose repression was
attenuated by Torin1 included Atg10, a regulator of
autophagosome formation (80), and Gstz1, which partici-
pates in cellular responses to oxidative stress (81).
(Supplementary Table S2). Another gene found in this
analysis was Sesn2, whose basal expression was not
affected by osmostress, but was reduced by Torin1 in
isotonic and hypertonic conditions (Supplementary
Table S3). Sesn2 can be induced by DNA damage, and
its product Sestrin 2 has been shown to inhibit mTOR via
TSC2 (21). Torin1 also enhanced the expression of Pdk4
and Pim1 in cells exposed to osmostress (Supplementary
Table S4). These genes have been described in the context
of cellular responses to starvation or inhibition of growth
signaling (82,83). The stress-related function of the differ-
ent genes is summarized in Supplementary Table S5. It is
important to note that the expression of several of these
genes was affected to a greater or lesser degree, but not
eliminated, upon inhibiting mTOR (Supplementary
Tables S1–S4), suggesting that this pathway regulated
their magnitude of induction but was not an absolute
requirement.
The ﬁnding that mTOR regulated the expression of a
complex pattern of genes raised the question of how they
might contribute to cell functions under stress. However,
since the contribution of mTOR to their magnitude of
expression varied depending on the particular gene, we
considered that trying to reproduce the effect of mTOR
inhibition by suppressing or overexpressing combinations
of genes would be complex. Nonetheless, we tested
whether mTOR activity was important to sustain growth
and proliferation capacity in cells exposed to osmostress.
For this approach, MEFs were labeled with the ﬂuores-
cent dye CFDA-SE and then cultured for 48 or 72h in
isotonic or hypertonic medium with or without rapamycin
or Torin1. As cells proliferate, the concentration of
CFDA-SE per cell decreases as the initial label is
distributed to daughter cells in successive rounds of
division. Besides CFDA-SE ﬂuorescence, we monitored
the overall viability and cell size by ﬂow cytometry.
MEFs exposed to osmotic stress proliferated more
slowly than those maintained in isotonic conditions,
but showed comparable viability and cell size (Figure 3A
and B). Inhibition of mTOR impaired cell proliferation
and caused a decrease in their size, clearly evident in
Torin1-treated cells, in both isotonic and hypertonic con-
ditions (Figure 3B). Visual examination of the cells
indicated no obvious signs of toxicity under the conditions
tested (Supplementary Figure S5). Altogether, these
results indicate that mTOR was required to sustain
growth and proliferative capacity during osmostress.
We were intrigued by the ﬁnding that hypertonic stress
upregulated the mTOR-dependent expression of REDD1
and REDD2 mRNAs, two homologous genes whose
products had been described to inhibit mTOR in certain
contexts, such as hypoxia (74,84). REDD1 protein, like its
mRNA, was induced by osmotic stress in a rapamycin and
Torin1-sensitive manner (Figure 4A). We could not asses
the induction of REDD2 protein due to the lack of
antibodies validated in the literature. We focused on
REDD1 and tested its effect on the activity of mTOR
and induction of osmoresponsive genes. Suppression of
REDD1 with siRNA did not affect the phosphorylation
of the mTORC1 substrate S6K1 (Figure 4B), which sug-
gested that induction of endogenous REDD1 by osmotic
stress did not inhibit mTOR, in contrast to its inhibitory
effect described in other stress responses. However, loss of
REDD1 in MEFs caused a decrease in the induction of
aldose reductase and Hsp70.1 by osmotic stress, without
affecting the induction of REDD2 (Figure 4C). In the
same set of experiments, downregulation of REDD2
with siRNA did not cause signiﬁcant changes in the in-
duction of osmostress response genes nor in the activity of
mTORC1 (Figure 4B and C). However, since we have not
conﬁrmed the induction of REDD2 protein, we are
cautious about the interpretation of this result regarding
the potential lack of effect of endogenous REDD2. Our
microarray analysis showed that inhibition of mTOR in
cells exposed to osmostress enhanced the expression of
Pdk4 (pyruvate dehydrogenase kinase 4) (Supplementary
Table S4). Since Pdk4 had been recently shown to be re-
pressed by REDD1 in MEFs (85), we tested whether
mTOR-mediated induction of REDD1 during osmostress
was involved in the inhibition of Pdk4, and found that
suppression of REDD1 prevented the downregulation of
PDK4 by osmotic stress to a similar extent as Torin1
(Figure 4C). Altogether, these results indicated that
although the effects of REDD1 were moderate, it could
modulate, both positively (aldose reductase, Hsp70.1) and
negatively (PDK4), the expression of several
osmoresponsive genes.
Nucleic Acids Research, 2012,Vol.40, No. 10 4375mTOR regulates osmostress-induced changes in chromatin
conﬁguration and RNA pol II recruitment to
osmoresponsive genes
Next, we analyzed the effect of mTOR inhibition on tran-
scriptional mechanisms potentially involved in the induc-
tion of osmostress responsive genes. We observed that
Torin1 did not inhibit the initial recruitment of NFAT5
to the Akr1b3 (aldose reductase) enhancer but caused its
partial dissociation from chromatin at later time points
(4h) (Figure 5A). We also observed that Torin1, and
rapamycin to a lesser extent, reduced the basal constitu-
tive nuclear accumulation of NFAT5 at 8h, but did not
impair its translocation induced by osmotic stress
(Supplementary Figure S6). These results indicated that
the activity of NFAT5 was reduced upon prolonged
mTOR inhibition. However, seeing that Torin1 inhibited
the induction of only a set (22%) of NFAT5-dependent
genes, as well as a similar proportion (25%) of
NFAT5-independent ones, we considered that NFAT5
might not be a primary target of mTOR, and wondered
whether Torin1 might affect other transcription regulatory
mechanisms. Prompted by a recent work showing that
hypertonic stress-induced rapid changes in the chromatin
conﬁguration of the aldose reductase gene (86), we asked
whether mTOR could regulate these processes in NFAT5-
dependent and -independent osmostress-responsive genes.
In agreement with Tong et al. (86), our analysis of the
Akr1b3 (aldose reductase) gene showed that hypertonic
stress-induced extensive acetylation of histone H4 at dif-
ferent regions since the ﬁrst hour of stimulation, followed
by eviction of nucleosomes from the transcription start
site (TSS) and upstream regions (Figure 5B). Torin1 in-
hibited the acetylation of H4 throughout an extended
region of 7kb by 4h, but did not affect nucleosome
eviction (Figure 5B). We then tested the effect of
osmostress and Torin1 on H4 acetylation and eviction
in two other genes: the NFAT5-regulated Ddit4l
(REDD2), and the NFAT5-independent Bpgm (2,3-
bisphosphoglycerate mutase). The increase in H4 acetyl-
ation induced by osmotic stress in these genes was rather
modest in comparison with Akr1b3, but was still
Torin1-sensitive (Supplementary Figure S7). Similarly to
what we had observed in the Akr1b3 gene, osmotic stress
caused a progressive nucleosome eviction in Ddit4l and
Bpgm that was not affected by Torin1.
Figure 3. Effect of osmotic stress and mTOR inhibitors on cell growth and proliferative capacity. Immortalized MEFs were labeled with CFDA-SE
and cultured during 48 or 72h in isotonic (300mOsm/kg) or hypertonic medium (500mOsm/kg, upon addition of 100mM NaCl) without or with
rapamycin (50nM) or Torin1 (100nM). (A) Cell viability (FSC/SSC dot plots), (B) size (FSC parameter) and relative proliferation (proportional to
dilution of CFDA-SE signal) were analyzed by ﬂow cytometry. The FSC parameter in (B) was analyzed in cells in G1, gated by staining the culture
with the DNA dye Hoechst 33342. Flow cytometry graphics are representative of three independent experiments with similar results.
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the recruitment of RNA polymerase II, a more direct in-
dicator of transcriptional activity. Osmotic stress induced
a rapid and substantial recruitment of RNA pol II to the
TSS and transcribed region (exon 2) of Akr1b3
(Supplementary Figure S8). Inhibition of the
osmostress-induced RNA pol II recruitment by Torin1
was detected in 1h, and preceded the partial dissociation
of NFAT5 from the Akr1b3 enhancer, indicating that in-
hibition of RNA pol II was not due to the dissociation of
NFAT5 from upstream regions. Further analysis showed
that both rapamycin and Torin1 were signiﬁcantly effect-
ive at inhibiting the binding of RNA pol II to the TSS of
Akr1b3 (Figure 6), as well as the recruitment to the TSS
and exon2 of active forms of RNA pol II involved in
transcription initiation and elongation, identiﬁed respect-
ively by phosphorylated Ser5 and Ser2 in the heptad
repeat of the carboxy-terminal domain (CTD) of its
largest subunit Rbp1 (87). Regarding Bpgm, we observed
a moderate effect of osmostress in enhancing the recruit-
ment of RNA pol II and its phosphorylated Ser5 and Ser2
forms than for the Akr1b3 gene, but nonetheless this effect
was signiﬁcant and inhibited by either rapamycin or
Torin1 (Figure 6). For Ddit4l, binding of RNA pol II to
its TSS and transcribed regions was minimally increased
by osmostress compared to Akr1b3 and Bpgm (Figure 6).
The modest effect of osmostress in enhancing H4
acetylation of Ddit4l and its occupancy by RNA pol II
suggested that the osmostress-induced mTOR-sensitive
mechanism for upregulating its mRNA could either
involve chromatin-regulatory events different from those
regulating Akr1b3 and Bpgm, or additional post-
transcriptional mechanisms acting on RNA processing
or stability.
DISCUSSION
Our study reveals a previously unappreciated capacity of
mTOR to regulate the osmostress response by inﬂuencing
the transcription of stress-responsive genes. We used
hypertonic stress conditions (500mOsm/kg) sufﬁcient to
Figure 4. mTOR-sensitive induction of REDD1 by osmotic stress. (A) Immortalized MEFs or HEK293T cells were cultured during 8h in isotonic
(300mOsm/kg) or hypertonic medium (500mOsm/kg, upon addition of 100mM NaCl) without or with rapamycin (50nM) or Torin1 (100nM).
REDD1, phospho-S6K1 (Thr 389), S6K1 and b-actin (loading control) were detected by Western blotting. (B) Immortalized MEFs were transfected
with control non-targeting siRNA (scramble) or siRNA speciﬁc for REDD1 or REDD2. After 24h, they were cultured during 8h in isotonic
(300mOsm/kg) or hypertonic medium (500mOsm/kg, upon adding 100mM NaCl). (C) Effect of suppressing REDD1 and REDD2 on the
osmostress-mediated induction of REDD1, REDD2, aldose reductase (AR), Hsp70.1, and PDK4. RNA levels for each gene and condition were
normalized to L32 mRNA and are represented relative to the amount of mRNA in hypertonic conditions in cells transfected with control scramble
siRNA, which was given an arbitrary value of 100. Bars represent the mean±SEM of three independent experiments (*P<0.05; n.s. not statistically
signiﬁcant).
Nucleic Acids Research, 2012,Vol.40, No. 10 4377induce a robust cellular response, but moderate enough so
that cells could adapt to it. These conditions allowed cells
to maintain mTORC1 and mTORC2 functioning and did
not activate AMPK. The ﬁnding that rapamycin sup-
pressed mTORC1, but not mTORC2, in cells exposed to
osmostress, together with the comparable inhibitory effect
of rapamycin and Torin1 on several osmoresponsive genes
indicate that at least mTORC1 is capable of osmoregula-
tory function. Nonetheless, our results do not rule out that
mTORC2 might also regulate the expression of some of
the osmostress-sensitive genes identiﬁed in the microarray
analysis.
Figure 5. Effect of Torin1 on the recruitment of NFAT5 to the Akr1b3 (aldose reductase) gene and its chromatin conﬁguration in response to
osmostress. (A) Chromatin from immortalized MEFs cultured in isotonic (300mOsm/kg) or hypertonic medium (500mOsm/kg, upon addition of
100mM NaCl) without or with Torin1 (100nM) was immunoprecipitated with preimmune rabbit serum (Pre) or a mixture of two rabbit polyclonal
antibodies speciﬁc for NFAT5 (NFAT5). Immunoprecipitated chromatin was ampliﬁed with primers for a genomic region located at 1.13-kb
upstream of the TSS that contains three osmotic responsive elements (ORE), and normalized to its respective total chromatin input. Results are
represented relative to the sample of 4h of hypertonicity treatment (arbitrary value of 1). Bars represent the mean±SEM of four independent
experiments (*P<0.05). (B) Schematic representation of the Akr1b3 gene showing the location of the primers used for different regions. Chromatin
from immortalized MEFs cultured in isotonic (300mOsm/kg) or hypertonic medium (500mOsm/kg) without or with Torin1 (100nM) was
immunoprecipitated with a control rabbit IgG, an acetylated histone H4-speciﬁc rabbit antibody or a histone H4-speciﬁc rabbit antibody.
Immunoprecipitated chromatin was normalized to its respective total chromatin input. Upper graphics show the ratio of acetylated H4 to total
H4 at different time points and conditions relative to a sample of untreated cells (300mOsm/kg, time 0, arbitrary value of 1). Lower panels
correspond to the immunoprecipitation with the H4-speciﬁc antibody in the same samples. Results represent the mean±SEM of four independent
experiments (*P<0.05).
4378 Nucleic Acids Research, 2012,Vol.40, No. 10Inhibition of mTOR affected gene expression in differ-
ent ways: some genes required mTOR to be optimally
induced, others were not particularly responsive to hyper-
tonicity but needed mTOR to maintain their expression
under stress conditions, and even a few were
downregulated during osmostress in an mTOR-dependent
manner. The set of genes whose expression was sensitive to
mTOR in cells subjected to osmotic stress was enriched in
genes associated with stress responses, and included genes
whose expression had not been previously associated with
osmotic stress but were known to respond to other
stressor such as DNA damage, hypoxia or oxidative
stress (Supplementary Table S5). The ﬁnding that
mTOR inhibition affected the magnitude of induction of
most of them but did not suppress their expression
suggests that the mTOR pathway may play a modulatory
role rather than being absolutely required. The particular
sensitivity of a set of osmoresponsive genes to mTOR
activity might represent one facet of the larger regulatory
effect of metabolic and cell growth status on gene
Figure 6. Effect of rapamycin and Torin1 on the recruitment of RNA pol II to osmostress responsive genes. Formaldehyde-crosslinked chromatin
from immortalized MEFs cultured during 4h in isotonic (300mOsm/kg) or hypertonic medium (500mOsm/kg, upon addition of 100mM NaCl)
without or with 50nM rapamycin (Ra) or 100nM Torin1 (T1) was immunoprecipitated with a control rabbit IgG, antibodies speciﬁc for RNA pol II
or for phosphorylated Ser5 or Ser2 in its CTD heptad repeat. Immunoprecipitated chromatin was analyzed with primers corresponding to the
proximal promoter/TSS and transcribed exonic regions of Akr1b3 (intron 1–exon 2), Bpgm (exon 2) and Ddit4l (exon 3) genes, and normalized to its
respective total chromatin input for each sample. Results are shown relative to the sample of 4h of hypertonicity treatment (arbitrary value of 1),
and represent the mean±SEM of three independent experiments (*P<0.05).
Nucleic Acids Research, 2012,Vol.40, No. 10 4379expression patterns, and indicate that the proﬁle of stress
responses elicited in actively growing cells differs from
those of cells with lower biosynthetic and metabolic
activity.
Cells kept under sustained osmotic stress maintained
their size, indicative of active biosynthesis, and could pro-
liferate, though at a slower rate than unstressed cells. Both
functions required active mTOR, which indicated that its
net effect in cells exposed to osmostress is to sustain
growth and cycling capacity. Inhibition of mTOR in
cells exposed to moderate osmostress up to 72h arrested
proliferation and growth, but did not decrease cell via-
bility. This could suggest that cells can survive despite
expressing lower levels of those genes that are more
dependent on mTOR, or that the restriction in
growth-promoting processes enforced by mTOR inhib-
ition could have a protective effect under stress. Both
possibilities are not mutually exclusive. Inhibiting
mTOR reduced the expression of 22% of osmostress-
induced genes, to a greater or lesser extent depending on
the gene, but did not suppress the entire osmostress
response. By contrast, lack of NFAT5 affected a much
greater proportion of osmostress-inducible genes (74%).
The interpretation that cells exposed to osmostress could
tolerate better the inhibition of mTOR than the lack of
NFAT5 is in agreement with the low renal toxicity of
rapamycin in patients (88), in contrast with the severe
renal dysfunction of NFAT5-deﬁcient mice (46). Since
cells in the renal medulla are naturally exposed to
elevated hypertonicity, a substantial inhibition of their
adaptive response would be highly deleterious, as
evidenced by the atrophy of the renal medulla observed
in NFAT5-deﬁcient mice (46), consistent with the depend-
ence of a majority of osmoresponsive genes on this factor.
It is also possible that inhibiting mTOR could have an
overall protective effect under stress despite that cells ex-
pressed lower levels of osmoregulatory gene products. At
least in other stress contexts, such as DNA damage or
glucose deprivation, inhibition of mTOR helps to
maintain cell viability and prevent replicative senescence,
whereas enforced mTOR activation in those conditions
leads to cell death (26,27,89,90). The biological meaning
of the reciprocal regulation between mTOR and stress re-
sponses is still largely unexplored. Since cells will likely be
exposed to a variety of stressors, intrinsic and extrinsic, as
well as growth signals throughout their lifespan, an
adequate balance of mTOR function could be relevant
to cope with stress and maintain growth capacity.
It was noticeable that mTOR enhanced the induction of
Ddit4 and Ddit4l in response to osmostress. The products
of these genes can inhibit the activity of mTORC1 in other
stress contexts, such as hypoxia (74,84), but our results
indicated that REDD1 did not seem to inhibit mTORC1
during the osmostress response. In this regard, independ-
ent studies have shown that REDD1 can be induced by
other stimuli, such as insulin, without causing mTOR in-
hibition (91), and that REDD1
/ MEFs do not exhibit
higher mTORC1 activity than wild-type ones under
normal growth conditions (85). Nonetheless, it is
possible that induction of REDD1 by osmostress could
cooperate with other types of stress to facilitate the
inhibition of mTOR. We observed that suppression of
REDD1 altered the expression of some mTOR-sensitive,
osmostress-regulated genes, which suggested a novel regu-
latory role of this protein. A recent work by Horak et al.
(85) described that REDD1 decreases the production of
mitochondrial reactive oxygen species, and this leads to
the destabilization of HIF-1a. Suppression of REDD1
increased HIF-1a levels and enhanced the expression of
several HIF-1a-regulated genes in normoxic conditions,
as well as other genes not known to be HIF-1a targets,
such as Pdk4 (85). Since hypertonicity can cause oxidative
stress, which contributes to the activation of
osmoresponsive genes (92), and can also activate HIF-1a
(93), it can be speculated that osmostress-induced REDD1
could serve to modulate the expression of genes sensitive
to oxidative stress and HIF-1a. Future work should elu-
cidate this question.
mTOR could modulate the expression of a set of
osmoresponsive genes by regulating epigenetic modiﬁca-
tions locally and facilitating the recruitment of RNA pol
II, as shown here for Akr1b3 and Bpgm. On the other
hand, another mTOR-regulated gene, Ddit4l, exhibited a
lesser responsiveness to osmostress for histone H4 acetyl-
ation and RNA pol II recruitment than Akr1b3 and Bpgm.
This could suggest that Ddit4l has an active-like chroma-
tin conﬁguration, as usually found in primary response
genes that are poised for rapid induction (94).
Alternatively, the mTOR-sensitive upregulation of its
mRNA by osmostress might involve chromatin-regulatory
events different from those regulating Akr1b3 and Bpgm,
or post-transcriptional mechanisms affecting its RNA
processing or stability. How is this achieved, and which
are the regulators involved are open questions. The more
pronounced sensitivity of a group of osmoresponsive
genes to mTOR suggests that it might modulate their ex-
pression through a limited set of regulators particularly
relevant for those genes, rather than affecting the
general transcription machinery of the cell. With regard
to NFAT5, we observed that its sustained binding to the
Akr1b3 enhancer was reduced upon prolonged mTOR in-
hibition. This effect could contribute to decrease the ex-
pression of aldose reductase mRNA and is likely
associated with the loss of acetylation in histone H4 at
this gene (86). However, other evidences indicated that
NFAT5 was not a primary determinant in the sensitivity
of osmoresponsive genes to mTOR: dissociation of RNA
pol II from Akr1b3 transcribed regions upon mTOR in-
hibition occurred before NFAT5 dissociated from its
enhancer; and inactivation of mTOR also inhibited the
osmostress-induced acetylation of H4 and RNA pol II
recruitment at the NFAT5-independent Bpgm gene, and
impaired the expression of similar proportions of
NFAT5-dependent and -independent genes. In addition,
>75% of the NFAT5-regulated genes were induced in an
mTOR-independent manner, and inactivation of mTOR
did not impair the synthesis and nuclear translocation of
NFAT5 induced by osmotic stress. In view of these results,
it is conceivable that mTOR might act upon different tran-
scriptional regulatory mechanisms, possibly involving
diverse transcription factors and chromatin modiﬁers,
to achieve the induction or repression of stress
4380 Nucleic Acids Research, 2012,Vol.40, No. 10responsive genes. In other contexts, mTOR has been
shown to enhance the induction of stress–response tran-
scription factors such as p53 and HIF-1a (27,28), and in-
ﬂuence histone acetylation at speciﬁc genes by diverse
mechanisms, such as inducing MyoD in mammalian
muscle cells, which suppresses the expression of the
histone deacetylase HDAC4 (95), or by inhibiting the as-
sociation of the HDACs Rpd3/Sin3 and Sir2 with nutrient
responsive genes in yeast (96,97) and promoting the re-
cruitment to them of histone acetyl transferase Esa1 (98).
The notion that mTOR can be an active regulator of
stress responses has been often overlooked under the con-
sideration that stress in general inhibits mTOR and this
serves to restrict cell growth and proliferation during
adverse conditions. However, our ﬁndings, together with
those from other laboratories, suggest that cells can use
this pathway to adjust the type and magnitude of stress–
responses to their growth status. The observation that
mTOR inhibition affected the expression of a group of
hypertonicity-responsive genes in proliferating cells also
suggests that actively growing cells exhibit, in an
mTOR-regulated manner, speciﬁc stress responses that
differ from those of less metabolically active cells in
their intensity and patterns of genes induced or sup-
pressed. Since growing cells have different needs than
less active ones, it is not unexpected that they may turn
on particular gene expression programs when facing
stress. Elucidating the functional relevance of this select-
ivity in different cell types deserves further investigation.
The activity of mTOR can be modulated by multiple vari-
ables including growth factors, cytokines, nutrients,
energy availability, the cell cycle phase and stress. Our
results support a role of mTOR in tuning the transcrip-
tional regulation of speciﬁc gene expression patterns to
inputs from stress and growth-regulatory signals.
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